speb/financial-data huggingface dataset:
CDM1.DE balance_sheet (annual, 2025-12-31) — Current Liabilities: 393144000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 393144000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Current Provisions: 15063000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Current Provisions: 15063000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Deferred Income Tax: -161015000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 14282000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Deferred Tax: -161015000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Deferred Tax: 14282000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 251099000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 73655000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 251099000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 73655000.00
CDM1.DE income_statement (annual, 2025-12-31) — Diluted Average Shares: 616707368.00
CDM1.DE income_statement (annual, 2025-12-31) — Diluted EPS: 0.95
CDM1.DE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 585872000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 214969000.00
CDM1.DE income_statement (annual, 2025-12-31) — EBIT: 711156000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — EBIT: 332895000.00
CDM1.DE income_statement (annual, 2025-12-31) — EBITDA: 962255000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — EBITDA: 406550000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 425000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 143000.00
CDM1.DE cash_flow (annual, 2025-12-31) — End Cash Position: 555705000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — End Cash Position: 555705000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -260631000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -25818000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Finished Goods: 104121000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Finished Goods: 104121000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Free Cash Flow: 665717000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 313268000.00
CDM1.DE income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 0.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 416000.00
CDM1.DE income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 1429000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 4364000.00
CDM1.DE income_statement (annual, 2025-12-31) — General And Administrative Expense: 57197000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 15205000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Goodwill: 625812000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 625812000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 625812000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 625812000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Gross PPE: 5222115000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 5222115000.00
CDM1.DE income_statement (annual, 2025-12-31) — Gross Profit: 920590000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Gross Profit: 385211000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 834000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 834000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Income Tax Payable: 116230000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 116230000.00
CDM1.DE income_statement (annual, 2025-12-31) — Interest Expense: 28618000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Interest Expense: 5387000.00
CDM1.DE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 28618000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 5387000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Interest Payable: 6060000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Interest Payable: 6060000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Inventory: 320791000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Inventory: 320791000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Invested Capital: 3603843000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3603843000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -127842000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -61383000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 10005000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 236000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 166500000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Land And Improvements: 9961000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 9961000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 32745000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 32745000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Long Term Debt: 290792000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 290792000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 323537000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 323537000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 166500000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CDM1.DE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -417886000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -23435000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Long Term Provisions: 262448000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 262448000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1741055000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1741055000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 93635000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CDM1.DE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 380000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -2051000.00
CDM1.DE income_statement (annual, 2025-12-31) — Net Income: 585872000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Net Income: 214969000.00
CDM1.DE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 585872000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 214969000.00
CDM1.DE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 585872000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 214969000.00
CDM1.DE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 585872000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 214969000.00
CDM1.DE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 585872000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 214969000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 585872000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 214969000.00
CDM1.DE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 585872000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 214969000.00
CDM1.DE income_statement (annual, 2025-12-31) — Net Interest Income: -30942000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Net Interest Income: -5968000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CDM1.DE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -251386000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -23435000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -251386000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -23435000.00
CDM1.DE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -30942000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -5968000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -9625000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -332000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -315000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -64000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Net PPE: 2744884000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Net PPE: 2744884000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2687239000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2687239000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 19683000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 19683000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 140553000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 140553000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 322983000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 322983000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 140553000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 140553000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 322983000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 322983000.00
CDM1.DE income_statement (annual, 2025-12-31) — Normalized EBITDA: 1030727000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 440744000.00
CDM1.DE income_statement (annual, 2025-12-31) — Normalized Income: 644620976.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Normalized Income: 237413184.53
CDM1.DE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 886879000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 374587000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Operating Gains Losses: 113000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 107000.00
CDM1.DE income_statement (annual, 2025-12-31) — Operating Income: 776801000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Operating Income: 366113000.00
CDM1.DE income_statement (annual, 2025-12-31) — Operating Revenue: 2070126000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Operating Revenue: 674847000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 642092761.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 642092761.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Other Current Assets: 29129000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 29129000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 124000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 124000.00
CDM1.DE income_statement (annual, 2025-12-31) — Other Gand A: 57197000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Other Gand A: 15205000.00
CDM1.DE income_statement (annual, 2025-12-31) — Other Income Expense: -63321000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Other Income Expense: -32637000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Other Inventories: 157461000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Other Inventories: 157461000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 75937000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 7871000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 192073000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 192073000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 80519000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 80519000.00
CDM1.DE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 5151000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1557000.00
CDM1.DE income_statement (annual, 2025-12-31) — Other Operating Expenses: 86592000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 3893000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Other Receivables: 1114000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1114000.00
CDM1.DE income_statement (annual, 2025-12-31) — Other Special Charges: 69901000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Other Special Charges: 51135000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Payables: 282567000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Payables: 282567000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 343487000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 343487000.00
CDM1.DE income_statement (annual, 2025-12-31) — Pretax Income: 682538000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Pretax Income: 327508000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Raw Materials: 59209000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 59209000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Receivables: 68326000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Receivables: 68326000.00
CDM1.DE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1149536000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 289636000.00
CDM1.DE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 251099000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 73655000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -417886000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -23435000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -9625000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -2287000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Retained Earnings: -2476389000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -2476389000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Sale Of Business: 93635000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CDM1.DE cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
CDM1.DE income_statement (annual, 2025-12-31) — Selling General And Administration: 57197000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 15205000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Share Issued: 642092761.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 642092761.00
CDM1.DE income_statement (annual, 2025-12-31) — Special Income Charges: -69901000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Special Income Charges: -38558000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 19209000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6682000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3313051000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3313051000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2687239000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2687239000.00
CDM1.DE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -9723024.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -11749815.47
CDM1.DE income_statement (annual, 2025-12-31) — Tax Provision: 96666000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Tax Provision: 112539000.00
CDM1.DE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.14
CDM1.DE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.34
CDM1.DE balance_sheet (annual, 2025-12-31) — Taxes Receivable: 49031000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 49031000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Total Assets: 4695682000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 4695682000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Total Capitalization: 3603843000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3603843000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Total Debt: 352495000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 352495000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 3313051000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3313051000.00
CDM1.DE income_statement (annual, 2025-12-31) — Total Expenses: 1293325000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 308734000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1382631000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1382631000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3723005000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3723005000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 989487000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 989487000.00
CDM1.DE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 707013000.00
CDM1.DE income_statement (annual, 2025-12-31) — Total Other Finance Cost: 2324000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 581000.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 133695000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 133695000.00
CDM1.DE income_statement (annual, 2025-12-31) — Total Unusual Items: -68472000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -34194000.00
CDM1.DE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -68472000.00
CDM1.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -34194000.00
CDM1.DE cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 342000.00
CDM1.DE cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CDM1.DE balance_sheet (annual, 2025-12-31) — Working Capital: 579533000.00
CDM1.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: 579533000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 52200000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 856192000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 258161000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 22882000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -2593804000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 12631608000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 99825000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 99825000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 690558000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Basic EPS: 0.36
CDM1.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 555705000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -74079000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -74079000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 57239000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 10345000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 843169000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 843169000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -104872000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 55373000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 340836000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Change In Inventory: -26803000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -71951000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -427000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4733000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -103914000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 291337000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 10345000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10412325000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 401000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 131840000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 429834000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 58868000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 1710178000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 25918000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 25918000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 5624000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 710000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 458378000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Current Notes Payable: 0.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Current Provisions: 19331000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -1565000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Deferred Tax: -1565000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 99825000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 99825000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 698689000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.35
CDM1.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 246761000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — EBIT: 354316000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — EBITDA: 454141000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1042000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 846000000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -104872000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Finished Goods: 429279000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 266757000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: -25000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 878000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 21662000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 625812000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 625812000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 14930388000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Gross Profit: 426358000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 834000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 82770000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 5601000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 5601000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Interest Income: 6225000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 6225000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Interest Payable: 1996000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Inventory: 728384000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 11128308000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 55373000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 401000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 84694000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 31321000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 715983000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 747304000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -10283000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 400720000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 2726479000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 128259000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 401000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Net Income: 246761000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 246761000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 246761000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 246761000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 246761000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 246761000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 246761000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -218000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -10283000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -10283000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -218000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -94990000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 1193000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 12336584000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 9786513000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 19857000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 144586000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3158651000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 144586000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 3158651000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 479805000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Normalized Income: 264931112.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 340836000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1554000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Operating Income: 374158000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 856192000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1034497016.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 50430000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1254000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Other Gand A: 21662000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Other Income Expense: -25225000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Other Inventories: 160433000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 89548000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 424310000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 83949000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 439000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 30538000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 6855000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Other Special Charges: 6607000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Payables: 347383000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 406251000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Pretax Income: 348715000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Raw Materials: 138672000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Receivables: 87361000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 429834000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 99825000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -10283000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 19910000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -2229628000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Sale Of Business: 128259000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 21662000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 1034497016.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Special Income Charges: -26542000.00
CDM1.DE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8627000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 10412325000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 9786513000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -7493888.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 101954000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 57624000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 15261327000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 11128308000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 773222000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 10412325000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 482034000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4849002000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 13551149000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 4390624000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 349170000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 842000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 89222000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -25664000.00
CDM1.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -25664000.00
CDM1.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: 1251800000.00
CDNA cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -1379000.00
CDNA cash_flow (annual, 2021-12-31) — Common Stock Issuance: 188855000.00
CDNA balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 139000.00
CDNA cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -106000.00
CDNA income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 106000.00
CDNA cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 1000.00
CDNA cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 188855000.00
CDNA cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -66000.00
CDNA cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -66000.00
CDNA cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -66000.00
CDNA balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 4726000.00
CDNA balance_sheet (annual, 2021-12-31) — Prepaid Assets: 7928000.00
CDNA cash_flow (annual, 2021-12-31) — Repayment Of Debt: -66000.00
CDNA income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
CDNA cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: 1743000.00
CDNA income_statement (annual, 2022-12-31) — +Operating Expense: 286812000.00
CDNA income_statement (annual, 2022-12-31) — +Total Revenue: 321793000.00
CDNA balance_sheet (annual, 2022-12-31) — Accounts Payable: 9942000.00
CDNA balance_sheet (annual, 2022-12-31) — Accounts Receivable: 66312000.00
CDNA balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -24424000.00
CDNA balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 898806000.00
CDNA cash_flow (annual, 2022-12-31) — Amortization Of Securities: 390000.00
CDNA cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 840000.00
CDNA income_statement (annual, 2022-12-31) — Basic Average Shares: 53321625.00
CDNA income_statement (annual, 2022-12-31) — Basic EPS: -1.44
CDNA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 348696000.00
CDNA cash_flow (annual, 2022-12-31) — Capital Expenditure: -24334000.00
CDNA cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -21234000.00
CDNA balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 38997000.00
CDNA balance_sheet (annual, 2022-12-31) — Capital Stock: 52000.00
CDNA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 89921000.00
CDNA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 293089000.00
CDNA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -4535000.00
CDNA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -228502000.00
CDNA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -25239000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Account Payable: -2054000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 2076000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Inventory: -2859000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -3456000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -215000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Payable: -2054000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 22000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1049000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Receivables: -6660000.00
CDNA cash_flow (annual, 2022-12-31) — Change In Working Capital: -14217000.00
CDNA cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -6660000.00
CDNA cash_flow (annual, 2022-12-31) — Changes In Cash: -258276000.00
CDNA balance_sheet (annual, 2022-12-31) — Common Stock: 52000.00
CDNA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 430911000.00
CDNA cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CDNA cash_flow (annual, 2022-12-31) — Common Stock Payments: -642000.00
CDNA balance_sheet (annual, 2022-12-31) — Construction In Progress: 7639000.00
CDNA income_statement (annual, 2022-12-31) — Cost Of Revenue: 112212000.00
CDNA balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 33795000.00
CDNA balance_sheet (annual, 2022-12-31) — Current Assets: 387849000.00
CDNA balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 5591000.00
CDNA balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5591000.00
CDNA balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 7404000.00
CDNA balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 5342000.00
CDNA balance_sheet (annual, 2022-12-31) — Current Liabilities: 75975000.00
CDNA cash_flow (annual, 2022-12-31) — Depreciation: 16007000.00
CDNA cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 16007000.00
CDNA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 16007000.00
CDNA balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 32000.00
CDNA income_statement (annual, 2022-12-31) — Diluted Average Shares: 53321625.00
CDNA income_statement (annual, 2022-12-31) — Diluted EPS: -1.44
CDNA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -76613000.00
CDNA income_statement (annual, 2022-12-31) — EBIT: -77231000.00
CDNA income_statement (annual, 2022-12-31) — EBITDA: -61224000.00
CDNA cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 23000.00
CDNA cash_flow (annual, 2022-12-31) — End Cash Position: 90443000.00
CDNA cash_flow (annual, 2022-12-31) — Financing Cash Flow: -4535000.00
CDNA balance_sheet (annual, 2022-12-31) — Finished Goods: 2962000.00
CDNA cash_flow (annual, 2022-12-31) — Free Cash Flow: -49573000.00
CDNA cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -107000.00
CDNA income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 107000.00
CDNA balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -7503000.00
CDNA income_statement (annual, 2022-12-31) — General And Administrative Expense: 100397000.00
CDNA balance_sheet (annual, 2022-12-31) — Goodwill: 37523000.00
CDNA balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 80574000.00
CDNA balance_sheet (annual, 2022-12-31) — Gross PPE: 94642000.00
CDNA income_statement (annual, 2022-12-31) — Gross Profit: 209581000.00
CDNA cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 392000.00
CDNA income_statement (annual, 2022-12-31) — Interest Income: 3762000.00
CDNA income_statement (annual, 2022-12-31) — Interest Income Non Operating: 3762000.00
CDNA cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 8000.00
CDNA balance_sheet (annual, 2022-12-31) — Inventory: 19232000.00
CDNA balance_sheet (annual, 2022-12-31) — Invested Capital: 430911000.00
CDNA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -228502000.00
CDNA cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CDNA balance_sheet (annual, 2022-12-31) — Leases: 17389000.00
CDNA balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 33406000.00
CDNA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 33406000.00
CDNA cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
CDNA balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 34925000.00
CDNA cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -610000.00
CDNA cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -642000.00
CDNA income_statement (annual, 2022-12-31) — Net Income: -76613000.00
CDNA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -76613000.00
CDNA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -76613000.00
CDNA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -76613000.00
CDNA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -76613000.00
CDNA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -76613000.00
CDNA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -76613000.00
CDNA cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -3100000.00
CDNA income_statement (annual, 2022-12-31) — Net Interest Income: 3762000.00
CDNA cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -203558000.00
CDNA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
CDNA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
CDNA income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 3762000.00
CDNA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -8558000.00
CDNA balance_sheet (annual, 2022-12-31) — Net PPE: 70218000.00
CDNA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 350337000.00
CDNA balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 2418000.00
CDNA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CDNA income_statement (annual, 2022-12-31) — Normalized EBITDA: -61331000.00
CDNA income_statement (annual, 2022-12-31) — Normalized Income: -76697530.00
CDNA cash_flow (annual, 2022-12-31) — Operating Cash Flow: -25239000.00
CDNA cash_flow (annual, 2022-12-31) — Operating Gains Losses: -107000.00
CDNA income_statement (annual, 2022-12-31) — Operating Income: -77231000.00
CDNA income_statement (annual, 2022-12-31) — Operating Revenue: 321793000.00
CDNA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 53533250.00
CDNA balance_sheet (annual, 2022-12-31) — Other Current Assets: 9216000.00
CDNA balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2341000.00
CDNA balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -7503000.00
CDNA income_statement (annual, 2022-12-31) — Other Gand A: 100397000.00
CDNA income_statement (annual, 2022-12-31) — Other Income Expense: -2765000.00
CDNA balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 43051000.00
CDNA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 727000.00
CDNA balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4350000.00
CDNA balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 249000.00
CDNA income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -2872000.00
CDNA balance_sheet (annual, 2022-12-31) — Other Properties: 34689000.00
CDNA balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 203168000.00
CDNA balance_sheet (annual, 2022-12-31) — Payables: 9942000.00
CDNA balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 43737000.00
CDNA balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 16902000.00
CDNA balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CDNA income_statement (annual, 2022-12-31) — Pretax Income: -76234000.00
CDNA cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 4665000.00
CDNA balance_sheet (annual, 2022-12-31) — Properties: 0.00
CDNA cash_flow (annual, 2022-12-31) — Purchase Of Business: -610000.00
CDNA cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -3100000.00
CDNA cash_flow (annual, 2022-12-31) — Purchase Of Investment: -315145000.00
CDNA balance_sheet (annual, 2022-12-31) — Raw Materials: 11964000.00
CDNA balance_sheet (annual, 2022-12-31) — Receivables: 66312000.00
CDNA income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 112212000.00
CDNA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 16007000.00
CDNA cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
CDNA cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -642000.00
CDNA income_statement (annual, 2022-12-31) — Research And Development: 90388000.00
CDNA income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
CDNA balance_sheet (annual, 2022-12-31) — Retained Earnings: -460444000.00
CDNA cash_flow (annual, 2022-12-31) — Sale Of Investment: 111587000.00
CDNA income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 96027000.00
CDNA income_statement (annual, 2022-12-31) — Selling General And Administration: 196424000.00
CDNA balance_sheet (annual, 2022-12-31) — Share Issued: 53533250.00
CDNA income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CDNA cash_flow (annual, 2022-12-31) — Stock Based Compensation: 46553000.00
CDNA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 430911000.00
CDNA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 350337000.00
CDNA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 22470.00
CDNA income_statement (annual, 2022-12-31) — Tax Provision: 379000.00
CDNA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CDNA balance_sheet (annual, 2022-12-31) — Total Assets: 542991000.00
CDNA balance_sheet (annual, 2022-12-31) — Total Capitalization: 430911000.00
CDNA balance_sheet (annual, 2022-12-31) — Total Debt: 38997000.00
CDNA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 430911000.00
CDNA income_statement (annual, 2022-12-31) — Total Expenses: 399024000.00
CDNA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 112080000.00
CDNA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 155142000.00
CDNA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 36105000.00
CDNA income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -77231000.00
CDNA income_statement (annual, 2022-12-31) — Total Unusual Items: 107000.00
CDNA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 107000.00
CDNA cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 1181000.00
CDNA balance_sheet (annual, 2022-12-31) — Work In Process: 4306000.00
CDNA balance_sheet (annual, 2022-12-31) — Working Capital: 311874000.00
CDNA income_statement (annual, 2023-12-31) — +Operating Expense: 285321000.00
CDNA income_statement (annual, 2023-12-31) — +Total Revenue: 280324000.00
CDNA balance_sheet (annual, 2023-12-31) — Accounts Payable: 12872000.00
CDNA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 51061000.00
CDNA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -32263000.00
CDNA balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 946511000.00
CDNA cash_flow (annual, 2023-12-31) — Amortization Of Securities: -4927000.00
CDNA cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 1000000.00
CDNA income_statement (annual, 2023-12-31) — Basic Average Shares: 53764705.00
CDNA income_statement (annual, 2023-12-31) — Basic EPS: -3.54
CDNA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 90443000.00
CDNA cash_flow (annual, 2023-12-31) — Capital Expenditure: -9240000.00
CDNA cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -8344000.00
CDNA balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 34221000.00
CDNA balance_sheet (annual, 2023-12-31) — Capital Stock: 49000.00
CDNA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 82197000.00
CDNA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 235418000.00
CDNA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -29606000.00
CDNA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 40446000.00
CDNA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -18388000.00
CDNA cash_flow (annual, 2023-12-31) — Change In Account Payable: 2904000.00
CDNA cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 90706000.00
CDNA cash_flow (annual, 2023-12-31) — Change In Inventory: 54000.00